In this study, we isolated CTCs from prostate (n = 17) and pancreatic (n = 5) cancer patients using a disposable lateral magnetophoretic microseparator, comparing the isolated CTC count, white blood cell (WBC) depletion rate, and CTC purity based on the EpCAM and vimentin antibodies combination. The gene discussed is EPCAM; the disease is cancer.